Spectral Diagnostics (OTCMKTS:EDTXF) Posts Earnings Results, Hits Expectations

Spectral Diagnostics (OTCMKTS:EDTXF) announced its quarterly earnings data on Friday. The company reported ($0.01) earnings per share for the quarter, meeting the consensus estimate of ($0.01), Zacks reports.

Spectral Diagnostics Stock Down 2.5%

Shares of OTCMKTS:EDTXF traded down $0.02 during midday trading on Friday, hitting $0.68. The stock had a trading volume of 3,000 shares, compared to its average volume of 10,188. The company has a market capitalization of $201.15 million, a P/E ratio of -6.83 and a beta of 0.21. The company’s 50-day moving average price is $0.82 and its 200-day moving average price is $0.94. Spectral Diagnostics has a fifty-two week low of $0.64 and a fifty-two week high of $1.10.

Spectral Diagnostics Company Profile

Spectral Diagnostics Inc is a Canadian medical technology company focused on improving the diagnosis and treatment of sepsis and septic shock. The company develops products designed to identify endotoxin activity, an important factor in certain severe infections and inflammatory conditions.

Its principal diagnostic product is the Endotoxin Activity Assay, a blood test intended to measure a patient’s level of endotoxin activity and help identify individuals who may be at increased risk of developing severe sepsis.